In the current work, we have hypothesized that besides responding differently to the substrate type as well as to insulin, fatty livers must also have disturbed responses to the positive gluconeogenic modulators glucagon and fatty acids, both usually found in high levels in the blood of obese subjects with NAFLD [18,19,20,21]. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.